CTP Synthase 1 Is a Novel Therapeutic Target in Lymphoma

Lymphoma is the most common hematological malignancy and is among the 10 most prevalent cancers worldwide. Although survival has been improved by modern immunochemotherapeutic regimens, there remains a significant need for novel targeted agents to treat both B-cell and T-cell malignancies. Cytidine...

Descripción completa

Detalles Bibliográficos
Autores principales: Asnagli, Hélène, Minet, Norbert, Pfeiffer, Christina, Hoeben, Eef, Lane, Rebecca, Laughton, David, Birch, Louise, Jones, Geraint, Novak, Andrew, Parker, Andrew E., Ludwig, Heinz, Fischer, Alain, Latour, Sylvain, Beer, Philip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060080/
https://www.ncbi.nlm.nih.gov/pubmed/37008165
http://dx.doi.org/10.1097/HS9.0000000000000864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060080/
https://www.ncbi.nlm.nih.gov/pubmed/37008165
http://dx.doi.org/10.1097/HS9.0000000000000864

Ejemplares similares